A therapeutic dosage of amlodipine prevents vascular hyporeactivity induced in rats by lipopolysaccharide

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 357, Issue 3, 1998, Pages 252-259

  Salomone, Salvatore ^a   Morel, Nicole ^a   Godfraind, Théophile ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Amlodipine; Calcium Antagonist; Interleukin 1 ; Isolated rat aorta; Lipopolysaccharide (LPS); N( ) nitro L arginine; Nitric oxide (NO); Nitric oxide synthase induction (NOS induction)

Indexed keywords

AMLODIPINE; CALCIUM ANTAGONIST; INTERLEUKIN 1; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; DRUG EFFECT; ENDOTOXEMIA; ENZYME INDUCTION; IN VITRO STUDY; NONHUMAN; SALMONELLA TYPHI; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

AMLODIPINE; ANIMALS; AORTA; DOSE-RESPONSE RELATIONSHIP, DRUG; INTERLEUKIN-1; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCARDIUM; NITRIC OXIDE SYNTHASE; NITRITES; NOREPINEPHRINE; RATS; RATS, WISTAR; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS; VASODILATOR AGENTS;

EID: 0031915727     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/PL00005165     Document Type: Article

References (35)

1. Balligand JL, Ungureanu-Longrois D, Simmons WW, Pimental D. Malinski TA, Kapturczak M, Taha Z, Lowenstein CJ, Davidoff AJ, Kelly RA, Smith TW and Michel T (1994) Cytokine-indlucible nitric oxide synthase (iNOS) expression in cardiac myocytcs: characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro. J Biol Chem 269: 27580-27588
2. Bigaud M, Julou-Schaeffer G, Parratt JR, Stoclet JC (1990) Endotoxin-induced impairment of vascular smooth muscle contractions elicited hy different mechanisms. Eur J Pharmacol 190: 195-192
3. Bredt DS, Snyder SH (1990) Isolation of nitric oxide synthethase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87: 682-685
4. Brian JE, Heistad DD, Faraei FM (1995) Mechanisms of endotoxin-induced dilatation of cerebral arterioles. Am J Physiol 38: H783-H788
5. Busse R, Mulsch A (1990) Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells. FEBS Lett 275: 87-90
6. De Belder AJ, Radomski MW, Why HJ, Richardson PJ, Bucknall CA, Salas E, Martin JF, Moncada S (1993) Nitric oxide synthase activities in human myocardium. Lancet 341: 84-85
7. Fleming I, Gray GA, Stoclet JC (1993) Influence of endothelium on induction of the L-arginine-nitric oxide pathway in rat aortas. Am J Physiol 264: H1200-H 1207
8. Gross SS, Jaffe EA, Levi R, Kilboum RG (1991) Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by argininc analogs with a rank-order of potency characteristic of activated macrophages. Biochem Biophys Res Commun 178: 823-829
9. G-monomethyl-L-arginine or indomethacin. J Pharmacol Exp Ther 272: 452-459
10. Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC (1990) Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway. Am J Physiol 259: H1038-H1043
11. Lowry OH, Rosebrough NJ, Fair AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275
12. Matlib MA, French JF, Grupp IL, Van Gorp C, Grupp G, Schwartz A (1988) Vasodilatory action of amlodipine on rat aorta, pig coronary artery, human coronary artery, and on isolated Langendorff rat heart preparations. J Cardiovasc Pharmacol 12 [suppl 7]: S50-S54
13. Morel N, Godfraind T (1994) Selective interaction of the calcium antagonist amlodipine with the calcium channels in arteries of spontaneously hypertensive rats. J Cardiovasc Pharmacol 24: 524-533
14. Nunokawa Y, Ishida N, Tanaka S (1993) Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem Biophys Res Commun 191: 89-94
15. Packer M, Nicod P, Khandheria BR, Costello DL, Wasserman AG, Konstam MA, Weiss RJ, Moyer RR, Pinsky DJ, Abittan MH, Souhrada JF (1991) Randomized, multicenter, double-blind, placebo-controlled evaluation of amlodipine in patients with mild-to-moderate heart failure. J Am Coll Cardiol 17 [suppl]: 274A
16. Packer M, O'Connor CM, Ghali JK, Pressler ML, Carson PE, Belkin RN, Miller AB, Nueberg GW, Frid DJ, Wertheimer JH, Cropp AB, DeMets DL, for the PRAISE Study Group (1996) Effect of amlodipine on morbidity and mortality in severe chronic hearth failure. N Engl J Med 335: 1107-1114
17. Palmer RM, Asthon DS, Moncada S (1988) Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature 333: 664-666
18. Paya D, Stoclet JC (1990) Involvement of bradykinin and nitricoxide in the early hemodynamic-effects of lipopolysaccharide in rats. Shock 3: 376-379
19. Pieper JA (1996) Evolving role of calcium channel blockers in heart failure. Pharmacotherapy 16: 43S-49S
20. Rees DD, Cellek S, Palmer RMJ, Moncada S (1990) Dexamethasone prevents the induction by endotoxin of a nitric oxide syn-thase and the associated effects on vascular tone: an insight into endotoxin shock. Biochem Biophys Res Commun 173: 541-547
21. Salomone S, Silva CLM, Morel N, Godfraind T (1996) Facilitation of the vasorelaxant action of calcium antagonists by basal nitric oxide in depolarized artery. Naunyn-Schmiedeberg's Arch Pharmacol 354: 505-512
22. Schini VB, Vanhoutte PM (1992) Inhibitors of calmodulin impair the constitutive but not the inducible nitric oxide synthase activity in the rat aorta. J Pharmacol Exp Ther 261: 553-559
23. 2+-independent nitric oxide synthase in the myocardium. Br J Pharmacol 105: 575-580
24. Stopher DA, Beresford AP, Macrae PV, Humphrey MJ (1988) The metabolism and pharmacokinetics of amlodipine in humans and animals. J Cardiovasc Pharmacol 12 [suppl.7]: S55-S59
25. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T. Matsuo H (1995) Interleukin-1, tumor-necrosis-factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth-muscle cells. Biochem Biophys Res Commun 207: 25-32
26. Swierkosz TA, Mitchell JA, Warner TD, Botting R, Vane JR (1995) Co-induction of nitric oxide synthase and cyclo-oxygenase: interactions between nitric oxide and prostanoids. Br J Pharmacol 114: 1335-1342
27. Szabo C, Mitchell JA, Gross SS, Thiemermann C, Vane JR (1993a) Nifedipine inhibits the induction of nitric oxide synthase by bacterial lipopolysaccharide. J Pharmacol Exp Ther 265: 674-680
28. Szabo C, Thiemermann C, Vane JR (1993b) Dihydropyridine antagonists and agonists of calcium channels inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages. Biochem Biophys Res Commun 196: 825-830
29. Szabo C, Mitchell JA, Thiemermann C, Vane JR (1993c) Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 108:786-792
30. Thiemermann C, Wu C-C, Szabo C, Perretti M. Vane JR (1993) Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock. Br J Pharmacol 110: 177-182
31. Wakabayashi I, Hakate K, Kakishita E, Nagai K (1987) Diminution of contractile response of the aorta from endotoxin-injected rats. Eur J Pharmacol 141: 117-122
32. Wang WZ. Matsumori A, Yamada T, Shioi T., Okada I, Matsui S, Sato Y, Suzuki H, Shiota K, Sasayama S (1997) Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A posible mechanism through inhibition of nitric oxide production. Circulation 95: 245-251
33. Winlaw DS, Smythe GA, Keogh AM, Schyvens CG, Spratt PM, MacDonald PS (1994) Increased nitric oxide production in heart failure. Lancet 344: 373-374
34. Winlaw DS, Smythe GA, Keogh AM, Schyvens CG, Spratt PM, MacDonald PS (1995) Nitric oxide production and heart failure. Lancet 345: 390-391
35. Wu C-C, Szabo C, Chen S-J, Thiemermann C, Vane JR (1994) Activation of soluble guanylyl cyclase by a factor other than nitric oxide or carbon monoxide contributes to the vascular hyporeactivity to vasoconstrictor agents in the aorta of rats treated with endotoxin. Biochem Biophys Res Commun 201: 436-142